ACCURATE Trial - Operative Treatment of Acute Rotator Cuff Tear Related to Trauma

NCT ID: NCT02885714

Last Updated: 2025-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-31

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rotator cuff tear is a very common and disabling condition that can be related to acute trauma such as falling on the shoulder. A tear is associated with symptoms such as pain in abduction, abduction weakness and night pain. Rotator cuff tear surgery is a well-established form of treatment in acute rotator cuff tears, although beneficial results have been reported for both conservative and surgical treatment of rotator cuff tears. Rotator cuff tear repair surgery involves a considerable amount of re-ruptures, and it is possible that the repaired tendon do not heal despite surgical repair. On the other hand rotator cuff tears are also found in completely asymptomatic persons and the clinical significance of a rupture may be generally lower than estimated. The above-mentioned factors, as well as recent research and meta-analysis on the treatment of mainly degenerative rotator cuff tears indicate that there is a limited evidence that surgery is not more effective in treating symptomatic rotator cuff tear than conservative treatment alone. However, these previous research findings cannot be applied directly to traumatic tears, although degeneration can be considered always to contribute to the creation of a rotator cuff tear.

During few last decades, despite the lack of evidence on the superiority of one treatment over another, the use of surgery to treat this disorder has been substantially increased. Treatment expectations are found to be important in predicting patient related outcome measures. In addition, surgery itself may produce a profound placebo effect. There are no previous placebo-controlled trials on the topic of interest. In order to find out the true efficacy of surgical treatment of acute, trauma related rotator cuff tears involving mainly the supraspinatus tendon, the investigators have designed this multi-centre, randomized, placebo-controlled efficacy trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Rotator Cuff Tear Related to Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I

Placebo surgery + supervised specific exercises

Group Type PLACEBO_COMPARATOR

Placebo surgery and supervised specific exercises

Intervention Type PROCEDURE

The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated. Nothing is to be removed or excised and the use of any vapour or shaver device is not allowed. The presence of a full-thickness rotator cuff tear is verified. Altogether 3 to 5 small stab wounds are made in typical locations resembling locations of typical rotator cuff repair. The time spent in the operating theatre with patients in placebo group should resemble the time spent with patients in the active treatment group and hence give an impression of a rotator cuff repair.

Group II

Rotator cuff repair + supervised specific exercises

Group Type ACTIVE_COMPARATOR

Rotator cuff repair and supervised specific exercises

Intervention Type PROCEDURE

The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated and the presence of a full-thickness rotator cuff tear is verified. The cuff tear is repaired to its anatomic location using suture anchors according to surgeon preference. . A biceps tenotomy or tenodesis may be performed according to surgeon preference if the biceps tendon is noted to be frayed, unstable or inflamed. An additional acromioplasty may be performed according to surgeon preference.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo surgery and supervised specific exercises

The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated. Nothing is to be removed or excised and the use of any vapour or shaver device is not allowed. The presence of a full-thickness rotator cuff tear is verified. Altogether 3 to 5 small stab wounds are made in typical locations resembling locations of typical rotator cuff repair. The time spent in the operating theatre with patients in placebo group should resemble the time spent with patients in the active treatment group and hence give an impression of a rotator cuff repair.

Intervention Type PROCEDURE

Rotator cuff repair and supervised specific exercises

The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated and the presence of a full-thickness rotator cuff tear is verified. The cuff tear is repaired to its anatomic location using suture anchors according to surgeon preference. . A biceps tenotomy or tenodesis may be performed according to surgeon preference if the biceps tendon is noted to be frayed, unstable or inflamed. An additional acromioplasty may be performed according to surgeon preference.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age of patient over 45 and below 70 years
2. Acute onset of shoulder symptoms after a traumatic event (any kind of sudden stretch, pull, fall, or impact, on the shoulder that is associated with the onset of symptoms)
3. Shoulder symptoms relating to rotator cuff tear = pain laterally on the shoulder and/or painful motion arc during abduction or flexion
4. MRI documented full thickness supraspinatus (ssp) tear

Exclusion Criteria

1. Traumatic event of the shoulder due a criminal act of violence with legal consequences
2. A delay of more than 4 months after the onset of symptoms of trauma to the day of intervention
3. Arthroscopically documented partial thickness rotator cuff tear only
4. A large MRI documented full thickness rotator cuff tear, sagittal tear size at the level of footprint larger than 3cm
5. MRI or arthroscopically documented total width of infraspinatus (isp) or subscapularis (ssc) tear
6. MRI or arthroscopically documented fully dislocated biceps tendon (biceps out of the groove) with concomitant subscapularis tear
7. Positive clinical rotatory lag sign (ER1 lag (\>10 degrees), lift off lag (involuntary drop against the back), horn blower lag (involuntary internal rotation of the forearm in supported elevated position))
8. Marked fatty degeneration in any of the cuff muscles (more than Fuchs/Goutallier grade 2)
9. Radiographically or MRI documented concomitant fracture line of the involved extremity or bony avulsion of the torn tendon or dislocation of the humeral head or the acromioclavicular joint.
10. Concomitant clinically detectable motoric nerve injury affecting the shoulder
11. Radiographically documented severe osteoarthritis of the glenohumeral joint, Samilson-Prieto 2 or above
12. Non-congruency of the glenohumeral joint in radiographs (Hamada stage 2 or above)
13. Clinical stiffness of the glenohumeral joint (severely limited passive range of motion: glenohumeral external rotation \< 30 degrees, and abduction with stabilized scapula \<60 degrees)
14. Previous surgery of the affected shoulder (affecting clavicle, scapula or upper third of the humerus)
15. Earlier sonographic or MRI finding of a rotator cuff tear
16. Previous symptoms of the ipsilateral shoulder requiring conservative treatment (glucocorticosteroid injections and/or physiotherapy) delivered by health care professionals during the last five years
17. Systemic glucocorticosteroid or antimetabolite medication during the last 5 years
18. Ongoing treatment for malignancy
19. ASA classification 3 or 4
20. Patient's inability to understand written and spoken Finnish, Norwegian or Swedish
21. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardise informed consent
22. Patients with a contraindication/noncomplience for MRI examination or use of electrocautery devices
23. Previous randomization of the contralateral shoulder into the ACCURATE trial
24. Patient's denial for operative treatment and/or participation in the trial
Minimum Eligible Age

45 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Turku University Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juha Kukkonen, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Satakunta Central Hospital

Anssi Ryösä, MD

Role: STUDY_CHAIR

Turku University Hospital

Hanna Björnsson Hallgren, MD, PhD

Role: STUDY_CHAIR

University Hospital, Linkoeping

Stefan Moosmayer, MD, PhD

Role: STUDY_CHAIR

Martina Hansens Hospital

Teresa Holmgren, PT, PhD

Role: STUDY_CHAIR

University Hospital, Linkoeping

Mats Ranebo, MD

Role: STUDY_CHAIR

Kalmar County Hospital

Berte Bøe, MD, PhD

Role: STUDY_CHAIR

Oslo University Hospital

Ville Äärimaa, Adj.Prof.

Role: STUDY_DIRECTOR

Turku University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Helsinki University Hospital

Helsinki, , Finland

Site Status

Central Finland Central Hospital

Jyväskylä, , Finland

Site Status

Kuopio University Hospital

Kuopio, , Finland

Site Status

Oulu University Hospital

Oulu, , Finland

Site Status

Satakunta Central Hospital

Pori, , Finland

Site Status

Hatanpää Hospital

Tampere, , Finland

Site Status

Tampere University Hospital

Tampere, , Finland

Site Status

Turku University Hospital

Turku, , Finland

Site Status

Vaasa Central Hospital

Vaasa, , Finland

Site Status

Sørlandet sykehus HF

Arendal, , Norway

Site Status

Oslo University Hospital, Ullevål Hospital

Oslo, , Norway

Site Status

Martina Hansens Hospital

Sandvika, , Norway

Site Status

St. Olafs Hospital HF

Trondheim, , Norway

Site Status

Skånevård Sund, Region Skåne

Helsingborg, , Sweden

Site Status

Kalmar County Hospital

Kalmar, , Sweden

Site Status

Linköping University Hospital

Linköping, , Sweden

Site Status

Varberg Hospital

Varberg, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland Norway Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Ryosa A, Kukkonen J, Bjornsson Hallgren HC, Moosmayer S, Holmgren T, Ranebo M, Boe B, Aarimaa V; ACCURATE study group. Acute Cuff Tear Repair Trial (ACCURATE): protocol for a multicentre, randomised, placebo-controlled trial on the efficacy of arthroscopic rotator cuff repair. BMJ Open. 2019 May 19;9(5):e025022. doi: 10.1136/bmjopen-2018-025022.

Reference Type DERIVED
PMID: 31110087 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACCURATE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rotator Cuff Injury to Surgery
NCT01744080 WITHDRAWN NA
Results of Rotator Cuff Repair
NCT01549912 COMPLETED